Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.
about
Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisMinimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesAdvancing the Minimal Residual Disease Concept in Acute Myeloid LeukemiaAssembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.Next generation MRD.Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use.The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.Patient selection for allogeneic hematopoietic cell transplantation (HCT): the evolution of HCT risk assessment.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults.Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature.Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making.T Cell Receptor Profiling in Type 1 Diabetes.Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.Molecular detection of minimal residual disease in multiple myeloma.Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia.Multi-loci diagnosis of acute lymphoblastic leukaemia with high-throughput sequencing and bioinformatics analysis.Reliability of immune receptor rearrangements as genetic markers for minimal residual disease monitoring.Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid MalignanciesSimple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL
P2860
Q26797245-E0C19D8B-2FD9-4AED-8989-0333DB20D5A5Q26828511-171AB5FB-CF64-45EB-8513-ACE0137EA43FQ28087291-D19B002C-CCD1-431F-820B-095D36F24599Q31123491-1244E338-5B56-4B90-AB2A-FB503B69BF8FQ33614375-FBED640F-14E2-48EC-8A21-7CD3DADB43B2Q34406955-2A6F6525-F0CF-42A4-8C64-4DDBD7A38DEEQ35100974-745EF360-4A3A-48EE-943A-F8D80B620C9FQ35650512-85741362-D36F-40FC-8B74-5E8B3BF54DB7Q35662007-31B1AF45-3B5F-407B-A0AB-2B8CC618F2C8Q35852353-D233FB8A-6D4E-4F9C-870C-639CF6ECA576Q36183310-885CF8FB-2A8A-40FE-814C-FB2FC93CA30CQ37702797-9AA1EE39-56A5-453D-9951-F1CF9CDF1584Q38287009-49A37BC7-3949-45F8-9621-7CA007B98059Q38672646-E5E14BFA-46E5-4EB1-9979-44B736C26AC8Q38777538-C452E6A5-9DB2-4CF1-AFA3-A59ECA14E247Q38815331-1F1059C3-58A4-490E-866C-00E593571525Q38901589-180F8701-F18F-4C5D-A755-5A474CD99DC3Q39035188-9DD9F953-D333-41B6-8110-249ACCFC391AQ39285841-782E8E60-5D39-4DD3-9642-B72B31DFCE44Q42374922-364D96CA-C60A-4440-8F35-7B35154EFB91Q42384499-D6FB47BA-5A14-4A46-8E94-FE63BFC0BDB1Q47603352-501E92BB-BBF5-4225-B03C-FFBF5F35A06CQ47873950-B3539B47-8E60-4402-860E-64D15AFC0A20Q48165946-01091EFC-839F-48A9-A205-D64CB543518DQ48268599-44EFA084-E7D9-469C-9C19-AA7ACFF067C8Q48371783-29150FE4-3D15-4F89-A3F9-963832F8E774Q50223693-4A19F005-9B77-435B-AC83-42BE4CE3CA14Q50230268-E27033DD-3F01-492E-86B2-D48340B1D78EQ51321225-58981047-3448-4DDB-A7C0-1627F7FB3784Q52735368-647B4354-7D8A-4D2E-8C71-AD7D2EFF07D0Q58723303-570C757E-1E18-4506-B1E1-CB8EC90CD41DQ58724470-F037142F-F9FE-4FA9-94C5-C02210AE9003
P2860
Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunoglobulin and T cell rece ...... antation relapse and survival.
@en
Immunoglobulin and T cell rece ...... antation relapse and survival.
@nl
type
label
Immunoglobulin and T cell rece ...... antation relapse and survival.
@en
Immunoglobulin and T cell rece ...... antation relapse and survival.
@nl
prefLabel
Immunoglobulin and T cell rece ...... antation relapse and survival.
@en
Immunoglobulin and T cell rece ...... antation relapse and survival.
@nl
P2093
P2860
P1476
Immunoglobulin and T cell rece ...... antation relapse and survival.
@en
P2093
Amna Waqar
Bing Zhang
David B Miklos
James L Zehnder
Jianbiao Zheng
Katherine Kong
Malek Faham
Mark Klinger
Martin Moorhead
Nikita Vashi
P2860
P304
P356
10.1016/J.BBMT.2014.04.018
P577
2014-04-24T00:00:00Z